136 related articles for article (PubMed ID: 22763474)
1. Magnesium sulfate therapy of preeclampsia: an old tool with new mechanism of action and prospect in management and prophylaxis.
Korish AA
Hypertens Res; 2012 Oct; 35(10):1005-11. PubMed ID: 22763474
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
3. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
4. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
5. Contribution of angiogenic factors in a rat model of pre-eclampsia.
Agunanne EE; Uddin MN; Horvat D; Puschett JB
Am J Nephrol; 2010; 32(4):332-9. PubMed ID: 20720407
[TBL] [Abstract][Full Text] [Related]
6. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
8. The effect of Kraussianone-2 (Kr2), a natural pyrano-isoflavone from Eriosema kraussianum, in an L-NAME- induced pre-eclamptic rat model.
Ramesar SV; Drewes SE; Gathiram P; Moodley J; Mackraj I
Phytother Res; 2012 Sep; 26(9):1375-80. PubMed ID: 22308016
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats.
Ramesar SV; Mackraj I; Gathiram P; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):136-40. PubMed ID: 21481522
[TBL] [Abstract][Full Text] [Related]
10. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
11. Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia.
Eshkoli T; Holcberg G; Bronfenmacher B; Amash A; Huleihel M; Erez O
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):116-22. PubMed ID: 22928533
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
[TBL] [Abstract][Full Text] [Related]
13. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
[TBL] [Abstract][Full Text] [Related]
14. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, and Soluble Fms-like Tyrosine Kinase-1 in peripheral blood mononuclear cells from normal and preeclamptic pregnancies.
Ali Z; Khaliq S; Zaki S; Ahmad HU; Lone KP
Chin J Physiol; 2019; 62(3):117-122. PubMed ID: 31249265
[TBL] [Abstract][Full Text] [Related]
16. The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia.
Weintraub AY; Amash A; Eshkoli T; Piltcher Haber E; Bronfenmacher B; Sheiner E; Holcberg G; Huleihel M
Hypertens Pregnancy; 2013 May; 32(2):178-88. PubMed ID: 23725083
[TBL] [Abstract][Full Text] [Related]
17. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
18. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
20. Pro-angiogenic therapeutics for preeclampsia.
Eddy AC; Bidwell GL; George EM
Biol Sex Differ; 2018 Aug; 9(1):36. PubMed ID: 30144822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
